CHU Amiens Picardie
Amiens, Picardie, 80054, France
Location status: Recruiting
NCT Number: NCT06084832
Alcohol use is a causal factor in more than 200 diseases and injury conditions (see ICD-10) and in France, alcohol is the first cause of hospitalization. Binge drinking (BD) has emerged as a major public health issue among student populations and is associated with negative consequences and social, cognitive and brain alterations. More than half of French university students have reported BD in the past month and are at increased risk of several alcohol-related consequences such as memory and sleep impairments, and reduced quality of life. BD is also a major risk factor in the development of alcohol addiction, with individual and environmental factors playing a role that is still poorly understood. Moreover, most students and young adults are reluctant to seek interventions when it is provided by health care professionals (only 4-5%) and have poor insight with regard to their alcohol use patterns / habits. Thus, there is an urgent need for developing effective prevention and intervention programs to reduce alcohol drinking in students. Recent studies have demonstrated that new types of technology-delivered interventions are promising tools for addressing unhealthy alcohol use. For example, an uncontrolled trial pilot study using a smartphone application-delivered intervention produced a reduction in both number of drinks per week and BD from baseline to 3-month follow-up. A recent review also showed significant outcomes of a mobile health intervention for self-control of unhealthy alcohol use. The investigators hypothesize that a timeline follow-back and personalized feedback based on the use of a mobile application can reduce excessive alcohol intake at 3-months. This study will provide scientific knowledge about BD in students, but also regarding a new type of intervention that could be effective for prevention in non-treatment seeking individuals and reducing the severity of health problems associated with excessive alcohol intake.
Interested in participating?
Request Info18 year–25 year
All sexes
Interventional
Not applicable
Amiens, Picardie, 80054, France
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
blood microsampling for the measure of Phosphatidylethanol
Time frame: 30 months
Time frame: 3 months
phosphatidylethanol (PEth)
Time frame: 6 months
phosphatidylethanol (PEth)
Time frame: 9 months
phosphatidylethanol (PEth)
Time frame: 12 months
phosphatidylethanol (PEth)
Time frame: 15 months
phosphatidylethanol (PEth)
Time frame: 18 months
phosphatidylethanol (PEth)
Time frame: 21 months
phosphatidylethanol (PEth)
Time frame: 24 months
phosphatidylethanol (PEth)
Time frame: 27 months
phosphatidylethanol (PEth)
Time frame: 30 months
phosphatidylethanol (PEth)
Interested in participating?
Request InfoCentre Hospitalier Universitaire, Amiens
Other
Smartphone Application for University Students With Binge Drinking Behavior: National Randomized Controlled Trial
Acronym: SmartBinge
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07591428
Alcohol Drinking, Alcohol-Related Disorders
Tulsa, Oklahoma, United States
View Trial DetailsNCT06318975
Alcohol Drinking, Alcohol-Related Disorders
San Antonio, Texas, United States
View Trial DetailsNCT05522075
Aging, Alcohol Abstinence
Arlington, Texas, United States
View Trial DetailsNCT06447350
Alcohol Drinking, Alcohol-Related Disorders
Caen, France
View Trial Details